Molecular Basis and Advances in Targeted Immunotherapy for Cancer
- PMID: 37175510
- PMCID: PMC10177995
- DOI: 10.3390/ijms24097802
Molecular Basis and Advances in Targeted Immunotherapy for Cancer
Abstract
Researchers have long attempted to stimulate the immune system of cancer patients as a therapeutic strategy [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
(R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment.J Natl Cancer Inst. 2014 Nov 27;107(1):347. doi: 10.1093/jnci/dju347. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25432410 Free PMC article.
-
Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives.Curr Cancer Drug Targets. 2023;23(4):251-264. doi: 10.2174/1568009623666221020104603. Curr Cancer Drug Targets. 2023. PMID: 36278447 Review.
-
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.Semin Oncol. 2015 Aug;42(4):601-16. doi: 10.1053/j.seminoncol.2015.05.007. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320064 Free PMC article. Review.
-
Molecular Imaging of Immunotherapy Targets in Cancer.J Nucl Med. 2016 Oct;57(10):1487-1492. doi: 10.2967/jnumed.116.177493. Epub 2016 Jul 28. J Nucl Med. 2016. PMID: 27469363 Free PMC article. Review.
-
Immunotherapy Advances: 2019.Oncology (Williston Park). 2019 Oct 28;33(10):686508. Oncology (Williston Park). 2019. PMID: 31661150
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical